Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Secco, G. B.
Right arrow Articles by Ferraris, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Secco, G. B.
Right arrow Articles by Ferraris, R.
Related Collections
Right arrow Other Colorectal

Annals of Surgical Oncology, Vol 7, Issue 1 32-37, Copyright © 2000 by Society of Surgical Oncology


ARTICLES

Is intensive follow-up really able to improve prognosis of patients with local recurrence after curative surgery for rectal cancer?

G. B. Secco, R. Fardelli, S. Rovida, D. Gianquinto, E. Baldi, P. Bonfante, L. Derchi and R. Ferraris
Department of Surgery (DICMI), University of Genoa School of Medicine, Italy.

BACKGROUND: Because more than 90% of local recurrences after curative surgery for rectal cancer appear within the first 36 months after surgery, an intensive and strict follow-up program during this period could improve early diagnosis and, thus, prognosis of patients. METHODS: Of the 216 patients who underwent surgery for rectal cancer, 127 entered an intensive follow-up program (median follow-up: 42 months); the clinical outcome of the remaining 89 patients was reconstructed with the help of their general practitioners. RESULTS: Fifty eight (26.8%) of the 216 patients who were treated with curative surgery alone developed a local recurrence; pelvic recurrences were prevalent. Eleven (30.5%) of the 36 patients who had recurrence during follow-up, and 6 of the 22 who had not undergone follow-up, had a reoperation with curative intent; the median survival was 19 months vs. 8 months, respectively (P = ns). Four (44.4%) curative reoperations were performed on the 9 asymptomatic patients and in 13 (26.5%) of the 49 cases with symptomatic local recurrences. Median survival was 15 months vs. 14 months, respectively (P = n.s). All patients except one (living after 42 months from reoperation) died within 48 months. CONCLUSIONS: In our study, adherence to a strict follow-up program unfortunately proved to be ineffective for improving long-term survival for patients who underwent reoperation with curative intent.


This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Hockel and N. Dornhofer
The Hydra Phenomenon of Cancer: Why Tumors Recur Locally after Microscopically Complete Resection
Cancer Res., April 15, 2005; 65(8): 2997 - 3002.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. J. Miner, D. P. Jaques, P. B. Paty, J. G. Guillem, and W. D. Wong
Symptom Control in Patients With Locally Recurrent Rectal Cancer
Ann. Surg. Oncol., January 1, 2003; 10(1): 72 - 79.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society of Surgical Oncology.